Early research (Phase 1)Study completedNCT06553209What this trial is testingStudy of CM512 in Healthy Subjects and Patients With Atopic DermatitisWho this might be right forAtopic Dermatitis Keymed Biosciences Co.Ltd 110
Post-approval studies (Phase 4)Study completedNCT04033367What this trial is testingSAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"Who this might be right forAtopic Dermatitis Sanofi 188
Testing effectiveness (Phase 2)Study completedNCT06790121What this trial is testingInvestigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisWho this might be right forDermatitis Atopic Sanofi 150
Large-scale testing (Phase 3)Looking for participantsNCT06389136What this trial is testingUpadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabWho this might be right forAtopic Dermatitis AbbVie 200
Testing effectiveness (Phase 2)UnknownNCT05671445What this trial is testingThe Study of CM326 in Adult Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Keymed Biosciences Co.Ltd 100
Not applicableEnrolling By InvitationNCT07503197What this trial is testingA Study on the Efficacy of 2% Cholesterol Cream in Atopic DermatitisWho this might be right forAtopic Dermatitis (AD)CholesterolSkin Barrier to Water Loss+3 more Institute of Dermatology, Thailand 30
Testing effectiveness (Phase 2)Study completedNCT03250624What this trial is testingSafety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Galderma R&D 63
Not applicableStudy completedNCT03863418What this trial is testingProbiotic Lactobacillus Rhamnosus GG for Pediatric Atopic DermatitisWho this might be right forAtopic Dermatitis Federico II University 100
Early research (Phase 1)Study completedNCT06342713What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological DiseasesWho this might be right forHealthy ParticipantsHealthy SubjectsHealthy Volunteers+4 more BeiGene 203
Testing effectiveness (Phase 2)Study completedNCT01859988What this trial is testingStudy of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Regeneron Pharmaceuticals 380
Testing effectiveness (Phase 2)Study completedNCT00146003What this trial is testingEfalizumab for EczemaWho this might be right forDermatitis, Atopic University of Medicine and Dentistry of New Jersey 10
Not applicableEnded earlyNCT04085549What this trial is testingEffects of a Berry Oil Cream on Atopic Eczema and SkinWho this might be right forAtopic Dermatitis Eczema Petra Larmo 83
Post-approval studies (Phase 4)Study completedNCT05642208What this trial is testingDupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic DermatitisWho this might be right forAtopic DermatitisEczema, Atopic Nantes University Hospital 256
Large-scale testing (Phase 3)Study completedNCT03796676What this trial is testingJAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic DermatitisWho this might be right forAtopic Dermatitis Pfizer 287
Large-scale testing (Phase 3)Study completedNCT04921969What this trial is testingAssess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)Who this might be right forAtopic Dermatitis Incyte Corporation 330
Testing effectiveness (Phase 2)Study completedNCT03903822What this trial is testingDose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Pfizer 292
Not applicableUnknownNCT05635266What this trial is testingTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesWho this might be right forAge-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more Sanguine Biosciences 20,000
Testing effectiveness (Phase 2)Study completedNCT04021862What this trial is testingEvaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic DermatitisWho this might be right forAtopic DermatitisEczema Janssen Research & Development, LLC 87
Large-scale testing (Phase 3)UnknownNCT03026946What this trial is testingAlitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand EczemaWho this might be right forHand Eczema University Medical Center Groningen 76
Not applicableActive Not RecruitingNCT04798079What this trial is testingSystems Biology of Early AtopyWho this might be right forAllergic DiseasesFood AllergyAtopic Dermatitis National Institute of Allergy and Infectious Diseases (NIAID) 2,500